Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.80 is 88% above its 5-year average of -22.50, near the high end of its 5-year range (-62.85–1.05).
123.11% below its 12-month average of -1.25.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.26.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 23 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:06:23.382Z. Historical observations retain their original dates. Historical series through 2025-05-15.
EARNINGS PER SHARE (EPS)
-2.80
EARNINGS PER SHARE (EPS) AVG TTM
-1.25
EARNINGS PER SHARE (EPS) AVG 3Y
-14.14
EARNINGS PER SHARE (EPS) AVG 5Y
-22.50
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-123.11%
CURRENT VS 3Y AVG
+80.20%
CURRENT VS 5Y AVG
+87.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Precision BioSciences, Inc.
Market Cap
$173.89M
Earnings Per Share (EPS)
-2.80
TTM Avg
-1.25
3Y Avg
-14.14
5Y Avg
-22.50
Market Cap
$172.65M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.56
3Y Avg
-2.45
5Y Avg
-2.61
Market Cap
$177.22M
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.39
3Y Avg
-0.36
5Y Avg
-0.55
Market Cap
$178.56M
Earnings Per Share (EPS)
-27.00
TTM Avg
-15.00
3Y Avg
-27.00
5Y Avg
-32.85
Market Cap
$179.31M
Earnings Per Share (EPS)
-1.57
TTM Avg
-5.27
3Y Avg
-99.59
5Y Avg
-93.21
Market Cap
$165.46M
Earnings Per Share (EPS)
-1.02
TTM Avg
-0.60
3Y Avg
-1.87
5Y Avg
-1.57
Market Cap
$182.88M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.59
3Y Avg
-0.77
5Y Avg
-0.88
Market Cap
$160.80M
Earnings Per Share (EPS)
-1.13
TTM Avg
-2.24
3Y Avg
-2.81
5Y Avg
-2.43
Market Cap
$159.74M
Earnings Per Share (EPS)
-0.90
TTM Avg
-1.19
3Y Avg
-2.61
5Y Avg
-1.83
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision BioSciences, Inc. (DTIL) | $173.89M | -2.80 | -1.25 | -14.14 | -22.50 |
| MediWound Ltd. (MDWD)vs › | $172.65M | -1.60 | -2.56 | -2.45 | -2.61 |
| Compass Therapeutics, Inc. (CMPX)vs › | $177.22M | -0.41 | -0.39 | -0.36 | -0.55 |
| Cue Biopharma, Inc. (CUE)vs › | $178.56M | -27.00 | -15.00 | -27.00 | -32.85 |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.31M | -1.57 | -5.27 | -99.59 | -93.21 |
| Coherus Oncology, Inc. (CHRS)vs › | $165.46M | -1.02 | -0.60 | -1.87 | -1.57 |
| Journey Medical Corporation (DERM)vs › | $182.88M | -0.23 | -0.59 | -0.77 | -0.88 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $160.80M | -1.13 | -2.24 | -2.81 | -2.43 |
| Inogen, Inc. (INGN)vs › | $159.74M | -0.90 | -1.19 | -2.61 | -1.83 |
| Anavex Life Sciences Corp. (AVXL)vs › | $158.01M | -0.26 | -0.53 | -0.57 | -0.55 |
Trailing EPS (TTM)
$-2.80
Forward EPS (Est.)
$-3.59
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.56 |
| 2024-12-31 | 1.05 |
| 2023-12-31 | -15.96 |
| 2022-12-31 | -38.10 |
| 2021-12-31 | -15.60 |
| 2020-12-31 | -62.85 |
| 2019-12-31 | -59.50 |
| 2018-12-31 | -28.17 |
| 2017-12-31 | -18.81 |
| 2016-12-31 | -0.49 |
